- A government-funded study on ultraprocessed foods pays participants $5,000 to follow diets rich in items like chicken nuggets. Preliminary results suggest these foods lead to higher calorie intake and weight gain, potentially shaping health policies.
- Weight-loss drugs like Ozempic are altering food preferences, encouraging less processed options.
- Food brands are adapting to “GLP-1 friendly” labels while researchers study potential long-term risks, such as vision loss.
Full Story
A new government-funded study is examining the health effects of ultraprocessed foods. Participants are being paid $5,000 to follow a diet heavy in processed items like chicken nuggets.
The Associated Press got an exclusive look into the study conducted at a government research facility. Its goal is to understand how these foods impact overall health. Researchers are particularly interested in ultraprocessed foods, which make up over 73% of the U.S. food supply, according to a Nature Communications study.
Junk food and health risks
Under strict supervision, participants alternated between ultraprocessed and less processed diets. Scientists monitored their calorie intake and physiological responses.
Early findings suggest that ultraprocessed foods lead to significantly higher calorie consumption and weight gain. One researcher told Fortune that the study’s short duration could limit results. However, the data may still influence future health policies.
“Make America Healthy Again” initiative
The study aligns with efforts by Health and Human Services Secretary Robert F. Kennedy Jr. His “Make America Healthy Again” initiative promotes the removal of certain artificial dyes and additives from food.
While Kennedy’s focus is on children’s health, he argues that ultraprocessed foods harm all age groups. However, one group may already be adjusting their diets.
Weight-loss drugs changing eating habits
A New York Times study highlights that GLP-1 weight-loss drugs, like Ozempic and Wegovy, are altering consumer habits. One subject, a former sugar addict, now finds processed sweets unappealing.
A professor at New York University told the Times that these drugs reduce appetites and rewire food preferences. Many users crave fresher, less processed options.
Big food companies react to shifting trends
Major food companies are feeling the effects of these dietary shifts. A PwC study found that GLP-1 users spend 11% less on food, particularly salty snacks and baked goods.
In response, brands like Conagra are launching “GLP-1 friendly” products. These items are labeled as high-protein and low-calorie to attract consumers using weight-loss medications.
Long-term effects of weight-loss drugs
However, the rise of GLP-1 drugs is not without concerns. Researchers are now studying their long-term effects. A February study is investigating a possible link between these medications and vision loss.
